Here are the ETFs to watch as biotech names bounce

Kevin O'Leary, O'Shares ETFs chairman, and Jim Lowell, Advisor Investments, join 'ETF Edge' on 'The Fast Money Halftime Report' discuss the bounce in biotech ETFs following news that President Trump is taking a Regeneron antibody treatment.
03:07
Mon, Oct 5 20203:50 PM EDT
RELATED VIDEOS
03:07
Here are the ETFs to watch as biotech names bounce
18:42
ETF Edge, June 22, 2020
08:20
Out of growth, into value? Investor lays out his top trades for the second half of 2020
04:27
How social media is helping drive the rush of retail investors to the stock market: Betterment
05:41
The psychology behind the retail investor comeback
01:26
ETF Edge: Credit Suisse delists several leveraged volatility ETFs
08:39
Transparency in Corporate America can help drive minority empowerment, ESG gains: NAACP ETF creators